CP
Basic information
Region (hg38): 3:149162410-149221829
Links
Phenotypes
GenCC
Source: 
- aceruloplasminemia (Strong), mode of inheritance: AR
 - aceruloplasminemia (Definitive), mode of inheritance: AR
 - aceruloplasminemia (Supportive), mode of inheritance: AR
 - aceruloplasminemia (Strong), mode of inheritance: AR
 - disorder of iron metabolism and transport (Limited), mode of inheritance: AD
 
Clinical Genomic Database
Source: 
| Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References | 
|---|---|---|---|---|---|
| Aceruloplasminemia | AR | Biochemical | In Aceruloplasminemia, medical management can be beneficial (eg, with iron chelating agents to decrease serum ferritin, brain and liver iron stores, and prevent progression of neurologic signs/symptoms; Combined IV desferrioxamine and fresh-frozen plasma can decrease liver iron content; repetitive FFP treatment can improve neurologic manifestations; antioxidants and oral zinc and deferasirox may prevent tissue damage to the liver and pancreas | Biochemical; Endocrine; Gastrointestinal; Neurologic; Ophthalmologic | 3574673; 1458725; 7820540; 7539672; 9066364; 20301666 | 
ClinVar
This is a list of variants' phenotypes submitted to 
- Deficiency_of_ferroxidase (476 variants)
 - not_provided (139 variants)
 - Inborn_genetic_diseases (130 variants)
 - not_specified (32 variants)
 - CP-related_disorder (31 variants)
 - Neurodegeneration_with_brain_iron_accumulation (7 variants)
 - Hypoceruloplasminemia (1 variants)
 - Hermansky-Pudlak_syndrome (1 variants)
 - . (1 variants)
 
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the CP gene is commonly pathogenic or not. These statistics are base on transcript: NM_000000096.4. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum | 
|---|---|---|---|---|---|---|
| synonymous | 111 | 123 | ||||
| missense | 10 | 279 | 28 | 327 | ||
| nonsense | 16 | 21 | ||||
| start loss | 1 | 1 | 2 | |||
| frameshift | 26 | 34 | ||||
| splice donor/acceptor (+/-2bp) | 14 | 21 | ||||
| Total | 65 | 29 | 290 | 139 | 5 | 
Highest pathogenic variant AF is 0.00009665248
GnomAD
Source: 
| Gene | Type | Bio Type | Transcript | Coding Exons | Length | 
|---|---|---|---|---|---|
| CP | protein_coding | protein_coding | ENST00000264613 | 19 | 59646 | 
| pLI Probability LOF Intolerant  | pRec Probability LOF Recessive  | Individuals with no LOFs  | Individuals with Homozygous LOFs  | Individuals with Heterozygous LOFs  | Defined | p | 
|---|---|---|---|---|---|---|
| 4.20e-10 | 1.00 | 114812 | 0 | 10936 | 125748 | 0.0445 | 
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
|---|---|---|---|---|---|---|
| Missense | 0.223 | 550 | 565 | 0.974 | 0.0000281 | 7076 | 
| Missense in Polyphen | 152 | 195.24 | 0.77853 | 2418 | ||
| Synonymous | -1.09 | 221 | 201 | 1.10 | 0.0000109 | 1926 | 
| Loss of Function | 3.66 | 25 | 54.1 | 0.462 | 0.00000262 | 689 | 
LoF frequencies by population
| Ethnicity | Sum of pLOFs | p | 
|---|---|---|
| African & African-American | 0.0682 | 0.0685 | 
| Ashkenazi Jewish | 0.0373 | 0.0368 | 
| East Asian | 0.0349 | 0.0351 | 
| Finnish | 0.0397 | 0.0395 | 
| European (Non-Finnish) | 0.0553 | 0.0556 | 
| Middle Eastern | 0.0349 | 0.0351 | 
| South Asian | 0.0326 | 0.0325 | 
| Other | 0.0490 | 0.0493 | 
dbNSFP
Source: 
- Function
 - FUNCTION: Ceruloplasmin is a blue, copper-binding (6-7 atoms per molecule) glycoprotein. It has ferroxidase activity oxidizing Fe(2+) to Fe(3+) without releasing radical oxygen species. It is involved in iron transport across the cell membrane. Provides Cu(2+) ions for the ascorbate-mediated deaminase degradation of the heparan sulfate chains of GPC1. May also play a role in fetal lung development or pulmonary antioxidant defense (By similarity). {ECO:0000250}.;
 - Disease
 - DISEASE: Note=Ceruloplasmin levels are decreased in Wilson disease, in which copper cannot be incorporated into ceruloplasmin in liver because of defects in the copper-transporting ATPase 2.;
 - Pathway
 - Porphyrin and chlorophyll metabolism - Homo sapiens (human);Ferroptosis - Homo sapiens (human);Post-translational protein phosphorylation;Post-translational protein modification;Metabolism of proteins;Transport of bile salts and organic acids, metal ions and amine compounds;SLC-mediated transmembrane transport;Transport of small molecules;Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs);Methionine and cysteine metabolism;Metal ion SLC transporters;Iron uptake and transport;HIF-1-alpha transcription factor network 
(Consensus)  
Recessive Scores
- pRec
 - 0.673
 
Intolerance Scores
- loftool
 - 0.0942
 - rvis_EVS
 - 0.25
 - rvis_percentile_EVS
 - 69.7
 
Haploinsufficiency Scores
- pHI
 - 0.433
 - hipred
 - Y
 - hipred_score
 - 0.652
 - ghis
 - 0.407
 
Essentials
- essential_gene_CRISPR
 - N
 - essential_gene_CRISPR2
 - N
 - essential_gene_gene_trap
 - N
 - gene_indispensability_pred
 - E
 - gene_indispensability_score
 - 0.928
 
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium | 
| Primary Immunodeficiency | Medium | Medium | Medium | 
| Cancer | Medium | Medium | Medium | 
Mouse Genome Informatics
- Gene name
 - Cp
 - Phenotype
 - immune system phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); vision/eye phenotype; hematopoietic system phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); pigmentation phenotype; liver/biliary system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); homeostasis/metabolism phenotype; cellular phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan);
 
Zebrafish Information Network
- Gene name
 - cp
 - Affected structure
 - otolith
 - Phenotype tag
 - abnormal
 - Phenotype quality
 - morphology
 
Gene ontology
- Biological process
 - copper ion transport;iron ion transport;cellular iron ion homeostasis;post-translational protein modification;cellular protein metabolic process;iron ion homeostasis;oxidation-reduction process
 - Cellular component
 - extracellular region;extracellular space;lysosomal membrane;endoplasmic reticulum lumen;plasma membrane;extracellular exosome;blood microparticle
 - Molecular function
 - ferroxidase activity;copper ion binding;oxidoreductase activity;chaperone binding